wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35930834-F3038F70-F5DF-45E8-A3DF-9E2BC11DBF3F
Q35930834-F3038F70-F5DF-45E8-A3DF-9E2BC11DBF3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35930834-F3038F70-F5DF-45E8-A3DF-9E2BC11DBF3F
Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticaria
P2860
Q35930834-F3038F70-F5DF-45E8-A3DF-9E2BC11DBF3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35930834-F3038F70-F5DF-45E8-A3DF-9E2BC11DBF3F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
016529bebe8495d4bab98a7801b4ac74b5b85967
P2860
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.